When the JDRF CCTN partnership was originally proposed, JDRF set a goal to initiate three human clinical trials in southern Ontario. I'm pleased to report that JDRF CCTN has exceeded that goal, initiating nine clinical trials and two technology projects. JDRF CCTN provides a platform for researchers and industry to test their treatments and technology sooner, ensuring that Canadian patients have access to the newest—